{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:12:19Z","timestamp":1746159139948,"version":"3.40.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,19]],"date-time":"2014-01-19T00:00:00Z","timestamp":1390089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Genet Med Rep"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s40142-014-0031-0","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T01:02:33Z","timestamp":1390006953000},"page":"23-29","source":"Crossref","is-referenced-by-count":8,"title":["Genetic Discoveries in AD Using CSF Amyloid and Tau"],"prefix":"10.1007","volume":"2","author":[{"given":"Carlos","family":"Cruchaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T. W.","family":"Ebbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S. K.","family":"Kauwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,19]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/bjp.122.1.15","volume":"122","author":"II Gottesman","year":"1973","unstructured":"Gottesman II, Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry. 1973;122:15\u201330.","journal-title":"Br J Psychiatry"},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/appi.ajp.160.4.636","volume":"160","author":"II Gottesman","year":"2003","unstructured":"Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636\u201345.","journal-title":"Am J Psychiatry"},{"key":"31_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0447.1986.tb10594.x","volume":"74","author":"ES Gershon","year":"1986","unstructured":"Gershon ES, Goldin LR. Clinical methods in psychiatric genetics. I. Robustness of genetic marker investigative strategies. Acta Psychiatr Scand. 1986;74:113\u20138.","journal-title":"Acta Psychiatr Scand"},{"key":"31_CR4","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Benitez BA, Karch CM, Cai Y, et al. The PSEN1, p.E318G variant increases the risk of Alzheimer\u2019s disease in APOE-\u03b54 carriers. PLoS Genet. 2013;9:e1003685. doi: 10.1371\/journal.pgen.1003685 . This article illustrates the successful use of next generation sequencing technologies with CSF biomarker data to discover novel AD risk variants. Here APP, PSEN1, PSEN3, GRN, MAPT and APOE were sequenced in 212 individuals with extreme CSF A\u03b242 or tau levels. Further analyses demonstrate that the effect of PSEN1, p.E318G on AD risk depends upon interaction with APOE \u03b54 and is mediated by A\u03b2 deposition.","DOI":"10.1371\/journal.pgen.1003685"},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2156-13-12","volume":"13","author":"DK Nolan","year":"2012","unstructured":"Nolan DK, Sutton B, Haynes C, et al. Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. BMC Genet. 2012;13:12. doi: 10.1186\/1471-2156-13-12 .","journal-title":"BMC Genet"},{"key":"31_CR6","doi-asserted-by":"crossref","first-page":"e11244","DOI":"10.1371\/journal.pone.0011244","volume":"5","author":"JM Shulman","year":"2010","unstructured":"Shulman JM, Chibnik LB, Aubin C, et al. Intermediate phenotypes identify divergent pathways to Alzheimer\u2019s disease. PLoS ONE. 2010;5:e11244. doi: 10.1371\/journal.pone.0011244 .","journal-title":"PLoS ONE"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan AM, Roe CM, Xiong C, et al. Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 2007;64:343\u20139. doi: 10.1001\/archneur.64.3.noc60123 .","journal-title":"Arch Neurol"},{"key":"31_CR8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000100926","volume":"23","author":"O Hansson","year":"2007","unstructured":"Hansson O, Zetterberg H, Buchhave P, et al. Prediction of Alzheimer\u2019s disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment. Dement Geriatr Cogn Disord. 2007;23:316\u201320. doi: 10.1159\/000100926 .","journal-title":"Dement Geriatr Cogn Disord"},{"key":"31_CR9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","volume":"14","author":"EN Kapaki","year":"2007","unstructured":"Kapaki EN, Paraskevas GP, Tzerakis NG, et al. Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer\u2019s disease. Eur J Neurol. 2007;14:168\u201373. doi: 10.1111\/j.1468-1331.2006.01593.x .","journal-title":"Eur J Neurol"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.21099","volume":"61","author":"JSK Kauwe","year":"2007","unstructured":"Kauwe JSK, Jacquart S, Chakraverty S, et al. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer\u2019s disease presenilin 1 mutation. Ann Neurol. 2007;61:446\u201353. doi: 10.1002\/ana.21099 .","journal-title":"Ann Neurol"},{"key":"31_CR11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2006.113803","volume":"78","author":"KL Brickell","year":"2007","unstructured":"Brickell KL, Leverenz JB, Steinbart EJ, et al. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2007;78:1050\u20135. doi: 10.1136\/jnnp.2006.113803 .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"e79771","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge PG, Mukherjee S, Crane PK, et al. Alzheimer\u2019s disease: analyzing the missing heritability. PLoS ONE. 2013;8:e79771. doi: 10.1371\/journal.pone.0079771 .","journal-title":"PLoS ONE"},{"key":"31_CR13","doi-asserted-by":"crossref","first-page":"e1001101","DOI":"10.1371\/journal.pgen.1001101","volume":"6","author":"C Cruchaga","year":"2010","unstructured":"Cruchaga C, Kauwe JSK, Mayo K, et al. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer\u2019s disease. PLoS Genet. 2010;6:e1001101. doi: 10.1371\/journal.pgen.1001101 .","journal-title":"PLoS Genet"},{"key":"31_CR14","author":"D Peterson","year":"2013","unstructured":"Peterson D, Munger C, Crowley J, et al. Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer\u2019s disease: the Cache County Dementia Progression Study. Alzheimers Dement. 2013;. doi: 10.1016\/j.jalz.2013.02.010 .","journal-title":"Alzheimers Dement"},{"key":"31_CR15","doi-asserted-by":"crossref","unstructured":"\u2022 Elias-Sonnenschein LS, Helisalmi S, Natunen T, et al. Genetic loci associated with Alzheimer\u2019s disease and cerebrospinal fluid biomarkers in a finnish case\u2013control cohort. PLoS ONE. 2013;8:e59676. doi: 10.1371\/journal.pone.0059676 . This study is one of just two that have systematically evaluated known AD risk variants for association with CSF biomarker levels. Evidence for association with CSF A\u03b242 was reported for variants in CLU and MS4A4A in 222 AD patients. These results suggest that these genes act to alter AD risk through an amyloid-related mechanism.","DOI":"10.1371\/journal.pone.0059676"},{"key":"31_CR16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ajmg.b.32094","volume":"159B","author":"LM Bekris","year":"2012","unstructured":"Bekris LM, Millard S, Lutz F, et al. Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:874\u201383. doi: 10.1002\/ajmg.b.32094 .","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"31_CR17","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Cruchaga C, Kauwe JSK, Harari O, et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer\u2019s disease. Neuron. 2013;78:256\u2013268. doi: 10.1016\/j.neuron.2013.02.026 . This article describes the largest genome-wide association study of CSF A\u03b242 and tau levels to date. The study included 1,269 samples with both CSF biomarker data and genetic data, and reported three genome-wide significant variants in addition to the APOE e4 allele. One variant, rs9877502, also showed association with risk for AD, tangle pathology and global cognitive decline in independent data sets.","DOI":"10.1016\/j.neuron.2013.02.026"},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","volume":"76","author":"S Kim","year":"2011","unstructured":"Kim S, Swaminathan S, Shen L, et al. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2011;76:69\u201379. doi: 10.1212\/WNL.0b013e318204a397 .","journal-title":"Neurology"},{"key":"31_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2377-10-90","volume":"10","author":"M-R Han","year":"2010","unstructured":"Han M-R, Schellenberg GD, Wang L-S, et al. Genome-wide association reveals genetic effects on human A\u03b242 and \u03c4 protein levels in cerebrospinal fluids: a case control study. BMC Neurol. 2010;10:90. doi: 10.1186\/1471-2377-10-90 .","journal-title":"BMC Neurol"},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/geno.1997.4782","volume":"43","author":"A Paoloni-Giacobino","year":"1997","unstructured":"Paoloni-Giacobino A, Chen H, Antonarakis SE. Cloning of a novel human neural cell adhesion molecule gene (NCAM2) that maps to chromosome region 21q21 and is potentially involved in Down syndrome. Genomics. 1997;43:43\u201351. doi: 10.1006\/geno.1997.4782 .","journal-title":"Genomics"},{"key":"31_CR21","doi-asserted-by":"crossref","first-page":"e18939","DOI":"10.1371\/journal.pone.0018939","volume":"6","author":"K Wang","year":"2011","unstructured":"Wang K, Li W-D, Zhang CK, et al. A genome-wide association study on obesity and obesity-related traits. PLoS ONE. 2011;6:e18939. doi: 10.1371\/journal.pone.0018939 .","journal-title":"PLoS ONE"},{"key":"31_CR22","doi-asserted-by":"crossref","first-page":"e1002695","DOI":"10.1371\/journal.pgen.1002695","volume":"8","author":"CS Fox","year":"2012","unstructured":"Fox CS, Liu Y, White CC, et al. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet. 2012;8:e1002695. doi: 10.1371\/journal.pgen.1002695 .","journal-title":"PLoS Genet"},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(00)02196-7","volume":"485","author":"GM Gibb","year":"2000","unstructured":"Gibb GM, Pearce J, Betts JC, et al. Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase-3 beta identified by nano-electrospray mass spectrometry. FEBS Lett. 2000;485:99\u2013103.","journal-title":"FEBS Lett"},{"key":"31_CR24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF02829548","volume":"26","author":"J Zhou","year":"2006","unstructured":"Zhou J, Chen J, Feng Y. Effect of truncated-ApoE4 overexpression on tau phosphorylation in cultured N2a cells. J Huazhong Univ Sci Technol Med Sci. 2006;26:272\u20134.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht WJ, Harris FM, Chang S, et al. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004;24:2527\u201334. doi: 10.1523\/JNEUROSCI.4315-03.2004 .","journal-title":"J Neurosci"},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling Y, Bien-Ly N, Xu Q, et al. Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci. 2010;30:13707\u201317. doi: 10.1523\/JNEUROSCI.4040-10.2010 .","journal-title":"J Neurosci"},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327. doi: 10.1056\/NEJMoa1211851 .","journal-title":"N Engl J Med"},{"key":"31_CR28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316. doi: 10.1056\/NEJMoa1211103 .","journal-title":"N Engl J Med"},{"key":"31_CR29","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;. doi: 10.1038\/ng.2802 .","journal-title":"Nat Genet"},{"issue":"1711","key":"31_CR30","first-page":"e15","volume":"34","author":"BA Benitez","year":"2013","unstructured":"Benitez BA, Cooper B, Pastor P, et al. TREM2 is associated with the risk of Alzheimer\u2019s disease in Spanish population. Neurobiol Aging. 2013;34(1711):e15\u20137. doi: 10.1016\/j.neurobiolaging.2012.12.018 .","journal-title":"Neurobiol Aging"},{"key":"31_CR31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.mp.4001935","volume":"12","author":"SM Laws","year":"2007","unstructured":"Laws SM, Friedrich P, Diehl-Schmid J, et al. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer\u2019s disease. Mol Psychiatry. 2007;12:510\u20137. doi: 10.1038\/sj.mp.4001935 .","journal-title":"Mol Psychiatry"},{"key":"31_CR32","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1073\/pnas.0801227105","volume":"105","author":"JSK Kauwe","year":"2008","unstructured":"Kauwe JSK, Cruchaga C, Mayo K, et al. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition. Proc Natl Acad Sci USA. 2008;105:8050\u20134. doi: 10.1073\/pnas.0801227105 .","journal-title":"Proc Natl Acad Sci USA"},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00406-012-0295-x","volume":"262","author":"L-H Guo","year":"2012","unstructured":"Guo L-H, Westerteicher C, Wang X-H, et al. SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci. 2012;262:529\u201334. doi: 10.1007\/s00406-012-0295-x .","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"31_CR34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/mp.2011.24","volume":"17","author":"N Brouwers","year":"2012","unstructured":"Brouwers N, Van Cauwenberghe C, Engelborghs S, et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites. Mol Psychiatry. 2012;17:223\u201333. doi: 10.1038\/mp.2011.24 .","journal-title":"Mol Psychiatry"},{"key":"31_CR35","doi-asserted-by":"crossref","unstructured":"\u2022 Kauwe JSK, Cruchaga C, Karch CM, et al. Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. PLoS ONE. 2011 6:e15918. doi: 10.1371\/journal.pone.0015918 . This study is the largest evaluation of known AD risk variants for association with CSF A\u03b242 and tau levels to date; 664 samples with biomarker and genetic data were used to test for association with variants in BIN1, CLU, CR1 and PICALM. There was marginal association between variants in CLU and PICALM and CSF A\u03b242, but the strongest findings suggest an assocoation between variants in PICALM and CSF pTau181 levels.","DOI":"10.1371\/journal.pone.0015918"},{"key":"31_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","volume":"9","author":"N Mattsson","year":"2013","unstructured":"Mattsson N, Andreasson U, Persson S, et al. CSF biomarker variability in the Alzheimer\u2019s association quality control program. Alzheimers Dement. 2013;9:251\u201361. doi: 10.1016\/j.jalz.2013.01.010 .","journal-title":"Alzheimers Dement"},{"key":"31_CR37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-2010-091711","volume":"21","author":"JSK Kauwe","year":"2010","unstructured":"Kauwe JSK, Cruchaga C, Bertelsen S, et al. Validating predicted biological effects of Alzheimer\u2019s disease associated SNPs using CSF biomarker levels. J Alzheimers Dis. 2010;21:833\u201342. doi: 10.3233\/JAD-2010-091711 .","journal-title":"J Alzheimers Dis"},{"key":"31_CR38","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","volume":"21","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C, Kauwe JSK, Nowotny P, et al. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer\u2019s disease. Hum Mol Genet. 2012;21:4558\u201371. doi: 10.1093\/hmg\/dds296 .","journal-title":"Hum Mol Genet"},{"key":"31_CR39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/mp.2013.24","volume":"18","author":"K Nho","year":"2013","unstructured":"Nho K, Corneveaux JJ, Kim S, et al. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry. 2013;18:781\u20137. doi: 10.1038\/mp.2013.24 .","journal-title":"Mol Psychiatry"},{"key":"31_CR40","author":"MTW Ebbert","year":"2013","unstructured":"Ebbert MTW, Ridge PG, Wilson AR, et al. Population-based analysis of Alzheimer\u2019s disease risk alleles implicates genetic interactions. Biol Psychiatry. 2013;. doi: 10.1016\/j.biopsych.2013.07.008 .","journal-title":"Biol Psychiatry"}],"container-title":["Current Genetic Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40142-014-0031-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40142-014-0031-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40142-014-0031-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:59:21Z","timestamp":1746115161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40142-014-0031-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,19]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s40142-014-0031-0","relation":{},"ISSN":["2167-4876"],"issn-type":[{"type":"electronic","value":"2167-4876"}],"subject":[],"published":{"date-parts":[[2014,1,19]]}}}